To some extent, future research with bigger sample sizes will help understand the pharmacological action in the IGF signaling system, along with the peripheral inflammatory state in BD patients that could shed some light on whether this family of proteins might protect against neuroinflammation under this mental condition and whether we can use them as potential diagnostic, prognostic, or monitoring biomarkers. The gene discussed is IGF1; the disease is Behcet disease.